Investor Alert

New York Markets After Hours

Jan. 17, 2020, 5:02 a.m. EST

Gluten-free products Market is expected to progress at healthy CAGR of 7.7% between 2019 and 2026 | Kraft Heinz Company, The Hain Celestial Group, Inc., Pinnacle Foods Inc., Others

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jan 17, 2020 (AmericaNewsHour) -- According to the current analysis of Reports and Data, the global Gluten-free products market was valued at USD 4.35 Billion in 2018 and is expected to reach USD 7.91 Billion by year 2026, at a CAGR of 7.7%. Gluten is a protein, naturally occurring in food-grains like wheat, barley, rye and spelt. Gluten is composed of two main proteins called glutenin and gliadin, out of which gliadin is responsible majorly for most of the health related issues. When it is mixed with water, the mixture results in glue like dough formation, it gives a soft and fluffy and yet elastic texture to the dough, in fact the name gluten is derived from glue like property possessed by this protein. This property provides elastic, fluffy, chewy texture and ability to rise when baked, to the dough; however, gluten consumption can create health issues in certain people.

Moreover, excess consumption of this products can lead to serious health issues like sensitivity, wheat allergy and celiac disease. According to the World Gastroenterology Organization (WGO), the celiac disease is affecting people from all the age groups including adults and elderly, while above 70% newly diagnosed patients and founded to be above 20 years of age. It is the diet which has a potential to cause intestinal damages by damaging the lining of the small intestine.

Key participants include Kraft Heinz Company (US), The Hain Celestial Group, Inc. (US), Pinnacle Foods Inc. (US), General Mills, Inc. (US), and Kellogg Company (US), Hero AG (Switzerland), Barilla GER Fratelli SPA (Italy), Pasia Plc (Finland), Genius Foods (UK), and Warburtons (UK).

Further key findings from the report suggest

  • Gluten-free products market is growing at a CAGR of 0% in Europe followed by North America and Asia Pacific, with 7.8 % and 7.4% CAGR, respectively. High prevalence of celiac disease among the population is expected to boost the industry.

  • As of 2018, Bakery product segment is the dominating the product market which holds 44.1% of the global market. North American regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions.

  • Dairy products market is expected to be the grow with a CAGR of 4%.during forecast period 2019-2026 .However, associated side effects and costs are major challenge for the industry growth.

  • Pizzas and Pastas type segment was valued at USD 696.2 million and is expected reach USD 1,232.8 million by 2026. Pastas is expected to show high demand in European countries especially in Italy, France, Spain and Germany.

  • The key players are adopting various strategies like partnerships, expansion, new product launch, new line launch and mergers & acquisitions. For example, the Conagra Brands acquired Pinnacle Foods Inc., with an objective to expand their business and market share.

  • According to a study, 3 million people in U.S. suffer from celiac disease, which means 1 in every 133 people is suffering from this severe intestinal disease, however, only 1 in every 4,700 people receive official diagnosis while the others are not aware of this making them sick.

  • Celiac is a hereditary disease with almost no permanent treatment. The only solution for the celiac disease patients is to adopt 100% gluten-free diet...Continued

For the purpose of this report, Reports and Data has segmented the Gluten-free products market on the basis of type, source type, distribution channel type and region:

Product Type (Revenue, USD Million; 2016-2026)

  • Bakery Products

  • Pizzas & Pasta

  • Desserts & Savories

  • Dairy Products

  • Meat & Meat alternatives Corticosteroids

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.